BMY FY 2015 Earnings — Bristol-Myers Squibb Company Revenue & Financial Results | Market Cap Arena

BMYBristol-Myers Squibb Company

$121B

FY 2015 Earnings

Healthcare Drug Manufacturers - General

Income Statement

Revenue

$16.6B+4.3% YoY

Gross Profit

$12.8B77.3% margin

Operating Income

$3.9B23.8% margin

Net Income

$1.6B9.5% margin

EPS (Diluted)

$0.97

Cash Flow

Operating Cash Flow

$2.1B

Free Cash Flow

$1.3B

Stock-Based Comp.

$235M

Balance Sheet

Total Assets

$31.7B

Total Liabilities

$17.3B

Stockholders' Equity

$14.3B

Cash & Equivalents

$2.4B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$16.6B	$15.9B	+4.3%
Gross Profit	$12.8B	$12.0B	+6.7%
Operating Income	$3.9B	$3.1B	+25.6%
Net Income	$1.6B	$2.0B	-21.9%